483 Biocon Biologics India Feb 2019

483 Biocon Biologics India Feb 2019

Diane Raccasi FDA, Michael Shanks FDA$119.00 - Available Now

FDA investigators audited the Biocon Biologics India - Bengaluru, India facility and issued inspectional observations (via FDA 483) on 15 Feb 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 15 Feb 2019
  • Location: Bengaluru, India
  • FEI: 3003981475
Add To Cart